New York pharma Pfizer has asked the U.S. Food and Drug Administration to give emergency-use authorization to the company’s messenger-RNA COVID-19 vaccine for U.S. residents from 6 months to 5 years old. All 24 million of them.
Experts say approval could come in a matter of weeks, and once the FDA gives Pfizer the nod to offer two doses of mRNA to under-5s, almost all Americans will be eligible for jabs.
Whether there'll be a massive uptick in vaccinations, however, is still up in the air. Many American parents have made it pretty clear in recent months that they’re in no hurry to get their kids vaccinated, despite the clear benefits of doing so—and the equally clear risks to not doing so.
